MedPath
NMPA Approval

Osimertinib Mesylate Tablets

国药准字HJ20181063

August 30, 2021

H20181063

Drug Information

甲磺酸奥希替尼片

泰瑞沙

泰瑞沙

片剂

80mg(按C28H33N7O2计)

化学药品

August 30, 2021

August 29, 2026

Company Information

Applicant Company

ASTRAZENECA AB

SE-151 85 Sodertalje, Sweden

Manufacturing Company

ASTRAZENECA AB

Gartunavagen, SE-151 85 Sodertalje, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.